HealthEquity Pre-Tax Income 2014-2024 | HQY
HealthEquity annual/quarterly pre-tax income history and growth rate from 2014 to 2024. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.
- HealthEquity pre-tax income for the quarter ending July 31, 2024 was $0.047B, a 227.73% increase year-over-year.
- HealthEquity pre-tax income for the twelve months ending July 31, 2024 was $0.131B, a 623.31% increase year-over-year.
- HealthEquity annual pre-tax income for 2024 was $0.075B, a 296.98% decline from 2023.
- HealthEquity annual pre-tax income for 2023 was $-0.038B, a 42.92% decline from 2022.
- HealthEquity annual pre-tax income for 2022 was $-0.067B, a 1712.1% decline from 2021.
| HealthEquity Annual Pre-Tax Income (Millions of US $) |
|
|---|---|
| 2024 | $75 |
| 2023 | $-38 |
| 2022 | $-67 |
| 2021 | $4 |
| 2020 | $43 |
| 2019 | $76 |
| 2018 | $52 |
| 2017 | $40 |
| 2016 | $26 |
| 2015 | $16 |
| 2014 | $5 |
| 2013 | $7 |
| HealthEquity Quarterly Pre-Tax Income (Millions of US $) |
|
|---|---|
| 2024-07-31 | $47 |
| 2024-04-30 | $33 |
| 2024-01-31 | $30 |
| 2023-10-31 | $21 |
| 2023-07-31 | $14 |
| 2023-04-30 | $10 |
| 2023-01-31 | $0 |
| 2022-10-31 | $-6 |
| 2022-07-31 | $-14 |
| 2022-04-30 | $-18 |
| 2022-01-31 | $-44 |
| 2021-10-31 | $-9 |
| 2021-07-31 | $-8 |
| 2021-04-30 | $-6 |
| 2021-01-31 | $-1 |
| 2020-10-31 | $4 |
| 2020-07-31 | $-1 |
| 2020-04-30 | $2 |
| 2020-01-31 | $-1 |
| 2019-10-31 | $-31 |
| 2019-07-31 | $24 |
| 2019-04-30 | $51 |
| 2019-01-31 | $16 |
| 2018-10-31 | $17 |
| 2018-07-31 | $21 |
| 2018-04-30 | $21 |
| 2018-01-31 | $7 |
| 2017-10-31 | $13 |
| 2017-07-31 | $16 |
| 2017-04-30 | $16 |
| 2017-01-31 | $6 |
| 2016-10-31 | $9 |
| 2016-07-31 | $13 |
| 2016-04-30 | $13 |
| 2016-01-31 | $4 |
| 2015-10-31 | $6 |
| 2015-07-31 | $7 |
| 2015-04-30 | $8 |
| 2015-01-31 | $2 |
| 2014-10-31 | $4 |
| 2014-07-31 | $5 |
| 2014-04-30 | $5 |
| 2014-01-31 | |
| 2013-10-31 | $3 |
| 2013-07-31 | $4 |
| 2013-01-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $9.104B | $1.000B |
| HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $93.361B | 11.58 |
| Cencora (COR) | United States | $48.280B | 17.81 |
| DiDi Global (DIDIY) | China | $22.212B | 0.00 |
| Natera (NTRA) | United States | $22.082B | 0.00 |
| ICON (ICLR) | Ireland | $17.675B | 15.74 |
| Viatris (VTRS) | United States | $15.958B | 4.92 |
| Avantor (AVTR) | United States | $14.143B | 21.20 |
| Revvity (RVTY) | United States | $13.634B | 23.68 |
| CochLear (CHEOY) | Australia | $12.777B | 0.00 |
| Solventum (SOLV) | United States | $12.233B | 0.00 |
| BioMerieux (BMXMF) | France | $11.895B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.498B | 29.58 |
| Charles River Laboratories (CRL) | United States | $10.011B | 19.34 |
| Doximity (DOCS) | United States | $8.999B | 52.97 |
| Sonic Healthcare (SKHHY) | Australia | $8.862B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.892B | 32.08 |
| Life Times (LTH) | United States | $5.081B | 33.63 |
| Organon (OGN) | United States | $3.935B | 3.97 |
| Sotera Health (SHC) | United States | $3.631B | 19.42 |
| BrightSpring Health Services (BTSG) | United States | $3.265B | 69.44 |
| Surgery Partners (SGRY) | United States | $2.925B | 33.35 |
| Concentras Parent (CON) | United States | $2.789B | 0.00 |
| PACS (PACS) | United States | $2.515B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.310B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.259B | 0.00 |
| Premier (PINC) | United States | $2.195B | 11.42 |
| GeneDx Holdings (WGS) | United States | $2.162B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.995B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.868B | 49.00 |
| Teladoc Health (TDOC) | United States | $1.828B | 0.00 |
| Progyny (PGNY) | United States | $1.315B | 26.62 |
| Pediatrix Medical (MD) | United States | $1.285B | 12.57 |
| CareDx (CDNA) | United States | $1.241B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.206B | 0.00 | |
| AMN Healthcare Services Inc (AMN) | United States | $0.984B | 6.66 |
| Embecta (EMBC) | United States | $0.797B | 5.32 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 0.00 |
| Agilon Health (AGL) | United States | $0.779B | 0.00 |
| SBC Medicals (SBC) | United States | $0.674B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.662B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.522B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.474B | 0.00 |
| DocGo (DCGO) | United States | $0.434B | 16.35 |
| Enhabit (EHAB) | United States | $0.380B | 32.87 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.302B | 0.00 |
| ModivCare (MODV) | United States | $0.254B | 13.79 |
| LifeMD (LFMD) | United States | $0.251B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.221B | 0.00 |
| Biodesix (BDSX) | United States | $0.186B | 0.00 |
| Nutex Health (NUTX) | United States | $0.179B | 0.00 |
| Beauty Health (SKIN) | United States | $0.176B | 0.00 |
| MultiPlan (MPLN) | United States | $0.112B | 0.00 |
| So-Young (SY) | China | $0.086B | 16.60 |
| Ascend Wellness Holdings (AAWH) | United States | $0.085B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.054B | 0.00 |
| OncoCyte (OCX) | United States | $0.046B | 0.00 |
| NeueHealth (NEUE) | United States | $0.041B | 1.10 |
| IceCure Medical (ICCM) | Israel | $0.032B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.032B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.031B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.021B | 0.00 |
| Oncology Institute (TOI) | United States | $0.012B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| KindlyMD (KDLY) | United States | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |